KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Receivables: 2009-2024

Historic Receivables for Astrana Health (ASTH) over the last 16 years, with FY2024 value amounting to $305.5 million.

  • Astrana Health's Receivables rose 19327.74% to $391.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $391.1 million, marking a year-over-year increase of 19327.74%. This contributed to the annual value of $305.5 million for FY2024, which is 29107.21% up from last year.
  • Astrana Health's Receivables amounted to $305.5 million in FY2024, which was up 29107.21% from $78.1 million recorded in FY2023.
  • In the past 5 years, Astrana Health's Receivables registered a high of $305.5 million during FY2024, and its lowest value of $56.3 million during FY2020.
  • Over the past 5 years, Astrana Health's median Receivables value was $78.1 million (recorded in 2023), while the average stood at $117.4 million.
  • As far as peak fluctuations go, Astrana Health's Receivables tumbled by 1625.7% in 2022, and later surged by 29107.21% in 2024.
  • Over the past 5 years, Astrana Health's Receivables (Annual) stood at $56.3 million in 2020, then soared by 42.02% to $80.0 million in 2021, then decreased by 16.26% to $67.0 million in 2022, then increased by 16.62% to $78.1 million in 2023, then surged by 291.07% to $305.5 million in 2024.
  • Its Receivables stands at $305.5 million for FY2024, versus $78.1 million for FY2023 and $67.0 million for FY2022.